logo
AbTherx and Spice Biotechnologies Announce Multi-Program Antibody Discovery Collaboration

AbTherx and Spice Biotechnologies Announce Multi-Program Antibody Discovery Collaboration

Immuno-oncology pioneer partners with AbTherx to build the next generation of immunotherapy drugs
MOUNTAIN VIEW, CA / ACCESS Newswire / May 12, 2025 / AbTherx, Inc., a biotechnology company with innovative transgenic technologies that enable and accelerate antibody discovery, today announced a multi-program antibody discovery partnership with Spice Biotechnologies. The partnership will leverage AbTherx's suite of innovative Atlas™ Mouse technologies to deliver antibodies against targets selected by Spice Bio.
AbTherx's antibody discovery platform is built on two decades of experience and utilizes evolutionary intelligence to identify diverse and developable human antibody sequences. This collaboration leverages AbTherx's novel, patent-pending Atlas Full Human Diversity Mouse, an updated industry standard with a strong IP position that generates fully human antibodies with the affinity and diversity required for efficient, successful drug development. It also utilizes the Binary Fixed Light Chain Transgenic Mouse which enables native-like IgG bispecific antibodies that improve manufacturability and developability. Through these innovative technologies and a deeply collaborative partnering model, AbTherx uniquely enables startups to efficiently manage resources, timelines, and technical risk.
Spice Bio was founded by Alan J. Korman, a globally recognized leader in immunology and cancer research. With over 30 years of experience in drug development, Dr. Korman has shaped groundbreaking advancements in the field, most recently serving as an executive at Vir Biotechnology and Bristol Myers Squibb. Dr Korman led the discovery of a revolutionary approach to cancer immune therapy and immune checkpoint blockade, which has driven the development and approval of several groundbreaking oncology drugs. Working with AbTherx cofounders at Medarex and BMS, Dr. Korman found incredible success discovering and developing the world's first immune checkpoint inhibitors, YERVOY® (ipilimumab) and OPDIVO® (nivolumab).
'Over the last 20 years, the Spice Bio team has had an incredible track record of creating successful life-saving drugs in partnership with some of our AbTherx cofounders. Because of this long, productive history, we are particularly excited to partner with Dr. Korman again in his new venture to create the next generation of immunotherapy drugs,' said Justin Mika, Chief Executive Officer of AbTherx. 'AbTherx is uniquely positioned to lead the next wave of antibody therapeutics with continuous innovation in antibody discovery technology, deep experience in antibody discovery, and startup-friendly partnering models.'
From top 10 pharmaceutical companies to virtual startups, leading organizations in antibody therapeutics have rapidly adopted the AbTherx platform, resulting in over 50 initiated programs across over a dozen partners in the past nine months. Under the terms of the agreement, Spice Bio has the right to develop and commercialize therapeutic antibodies resulting from the collaboration. AbTherx will receive research payments and is eligible to receive downstream clinical and commercial milestone payments, as well as royalties on net sales of products.
About AbTherx
AbTherx is advancing medicine with revolutionary technologies that accelerate and enable therapeutic antibody discovery. Through an exclusive license from Gilead Sciences, AbTherx has released Atlas™ Mice, a suite of novel transgenic technologies designed for unmatched performance and Freedom to Operate. For over 20 years, a core group of AbTherx's scientists have worked together to push the boundaries of antibody discovery technologies, resulting in more than 1,000 successful discovery campaigns and the development of 13 marketed therapeutics. AbTherx's industry-leading team creates transformative solutions to overcome the most demanding challenges in delivering innovative medicines. Committed to making its technologies accessible to all, AbTherx offers flexible partnering models that meet the needs of drug developers of all sizes. For more information, please visit www.abtherx.com.
Media Contact
Stacey Borders
[email protected]
SOURCE: AbTherx, Inc.
press release
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CEO Tim Cook says Apple ready to open its wallet to catch up in AI
CEO Tim Cook says Apple ready to open its wallet to catch up in AI

Yahoo

time17 minutes ago

  • Yahoo

CEO Tim Cook says Apple ready to open its wallet to catch up in AI

By Stephen Nellis SAN FRANCISCO (Reuters) -Apple CEO Tim Cook signaled on Thursday the iPhone maker was ready to spend more to catch up to rivals in artificial intelligence by building more data centers or buying a larger player in the segment, a departure from a long practice of fiscal frugality. Apple has struggled to keep pace with rivals such as Microsoft and Alphabet's Google, both of which have attracted hundreds of millions of users to their AI-powered chatbots and assistants. That growth has come at a steep cost, however, with Google planning to spend $85 billion over the next year and Microsoft on track to spend more than $100 billion, mostly on data centers. Apple, in contrast, has leaned on outside data center providers to handle some of its cloud computing work, and despite a high-profile partnership with ChatGPT creator OpenAI for certain iPhone features, has tried to grow much of its AI technology in-house, including improvements to its Siri virtual assistant. The results have been rocky, with the company delaying its Siri improvements until next year. During a conference call after Apple's fiscal third-quarter results, analysts noted that Apple has historically not done large deals and asked whether it might take a different approach to pursue its AI ambitions. CEO Cook responded that the company had already acquired seven smaller companies this year and is open to buying larger ones. "We're very open to M&A that accelerates our roadmap. We are not stuck on a certain size company, although the ones that we have acquired thus far this year are small in nature," Cook said. "We basically ask ourselves whether a company can help us accelerate a roadmap, and if they do, then we're interested." Apple has tended to buy smaller firms with highly specialized technical teams to build out specific products. Its largest deal ever was its purchase of Beats Electronics for $3 billion in 2014, followed by a $1 billion deal to buy a modem chip business from Intel. But now Apple is at a unique crossroads for its business. The tens of billions of dollars per year it receives from Google as payment to be the default search engine on iPhones could be undone by U.S. courts in Google's antitrust trial, while startups like Perplexity are in discussions with handset makers to try to dislodge Google with an AI-powered browser that would handle many search functions. Apple executives have said in court they are considering reshaping the firm's Safari browser with AI-powered search functions, and Bloomberg News has reported that Apple executives have discussed buying Perplexity, which Reuters has not independently confirmed. Apple also said on Thursday it plans to spend more on data centers, an area where it typically spends only a few billion dollars per year. Apple is currently using its own chip designs to handle AI requests with privacy controls that are compatible with the privacy features on its devices. Kevan Parekh, Apple's chief financial officer, did not give specific spending targets but said outlays would rise. "It's not going to be exponential growth, but it is going to grow substantially," Parekh said during the conference call. "A lot of that's a function of the investments we're making in AI." Sign in to access your portfolio

Hub Group is fully behind a potential UP-NS transcontinental railroad creation
Hub Group is fully behind a potential UP-NS transcontinental railroad creation

Yahoo

time17 minutes ago

  • Yahoo

Hub Group is fully behind a potential UP-NS transcontinental railroad creation

Hub Group, a major intermodal transportation provider and a company that would be on the front lines of a merger between Union Pacific and Norfolk Southern, likes what it sees. In the prepared statement released in conjunction with the company's second quarter earnings, Hub Group (NASDAQ: HUBG), said it was 'supportive' of the two companies and their merger plans to create the nation's first transcontinental railroad. . 'The announced transaction would further accelerate our long-term growth opportunity,' the company said. 'Specifically, a transcontinental network removes friction in gateways, reduces transit times, provides access to new markets, and increases competition with truck volume through new single-line service.' Can we talk about something else? When President and CEO Phil Yeager first brought up the merger on the company's call with analysts Thursday after the numbers and statement were released, he echoed the positive sentiments in the earnings release. But he also asked the analysts on the call to not focus on the merger and the impact it might have on Hub Group. 'We would appreciate questions being focused on the company and our results,' Yeager said. And then when the phone lines were open to questions, Yeager's request was promptly ignored and the first question was about the merger. Despite his earlier admonition, Yeager took the question and continued to express support for the creation of the cross-country rail supergiant. Yeager, in his prepared remarks, said Hub Group were 'exclusive partners' with both Union Pacific and Norfolk Southern. With the two of them together, he said, 'there are several catalysts that should create significant intermodal conversion,' citing 'improved fluidity' in gateway cities, 'faster transit, better asset utilization, enhanced fuel efficiency and access to additional lanes and markets.' Yeager said about 30% of the Hub Group's current business is 'moving in a transcontinental fashion.' But since there is no single transcontinental railroad–establishing one being the point of the Union Pacific-Norfolk Southern (NYSE: UNP) (NYSE: NSC) tieup–Yeager expressed optimism about the efficiencies that could come from the existence of such a system instead of needing transfers between regional railroads.. Yeager said on the call that the transcontinental business is 'typically a positive mix' for both revenue and margins. Optimism on the Marten acquisition Hub Group's earnings release was the first since it announced its plan to acquire the intermodal operations of Marten Transport (NASDAQ: MRTN). Yeager said the acquisition 'allows us to enhance our scale and capacity in one of the highest growth segments of our intermodal network,' which is refrigerated. While the Marten intermodal operations had been consistently running with an operating ratio in excess of 100% for several quarters, Yeager said he believes the operations inside Hub Group will ''expand our customer base while generating strong returns, due to our ability to capture synergies within our platform.' As for more purchases, Yeager said Hub Group has a 'robust pipeline of additional acquisitions designed to continue deploying capital toward long term growth opportunities.' Kevin Beth, the company's CFO, after reviewing a decidedly mixed and not overly optimistic outlook on the state of the freight business for the rest of the year, did note one sign of strength for rail transportation. 'It's very positive that we're seeing peak season surcharges in July, and we hopefully will see that momentum carried forward in August and September and through the remainder of the year as well,' Beth said. Beth, in response to an analyst question, said the surcharges Hub Group has seen in the market this year are larger than last year, but they also were implemented by railroads later this year than in 2024. Yeager said the company anticipates an early West Coast peak season as part of an 'inventory pull forward' driven by importers trying to get ahead of tariffs. But specific to Hub Group, he said, the company has had an 'improved bid realization rate' and has added several new dedicated customers, 'which should lead to higher revenue from current levels.' The company's second earnings reported that several financial measures were weaker for Hub Group in the quarter. Operating income declined 13.1% from the second quarter of 2024 to $34.3 million. Net income dropped 13.7% to just over $25 million. The cost of purchased transportation at Hub Group, which is easily the largest expense at the company, declined 9.8%. It accounted for 72.4% of all operating expenses, down from 73.7% a year earlier. Specific units of the company both reported significant declines in revenue, though the Intermodal and Transportation Solutions segment, which is the asset-heavy part of Hub Group, did see an increase in operating income. Revenue was $528 million, down from $561 million a year earlier. But operating income rose to $14.4 million from $13.6 million a year ago. Logistics revenue was $404 million, down from $459 million. Adjusted operating income for the segment was $23 million compared to $26 million a year earlier. Sequentially, results at Hub Group were mostly weaker but only by minor amounts. Operating revenue sequentially dropped 1%. Purchased transportation was down less than half a percentage point. But operating income was down 8%. And net income declined 7.1%. Total legacy headcount, which excludes acquisition employees, drivers and warehouse employees, declined 3% from prior year. More articles by John Kingston Averitt pay increase could be a sign of some acceleration in driver wages Sequential numbers at diversified trucking operator TFI International may mark a turnaround At C.H. Robinson, improved profitability, productivity and a lot fewer workers The post Hub Group is fully behind a potential UP-NS transcontinental railroad creation appeared first on FreightWaves. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

It's Liberation Day III - and from today, dozens of countries will face painful Trump tariffs
It's Liberation Day III - and from today, dozens of countries will face painful Trump tariffs

Yahoo

time17 minutes ago

  • Yahoo

It's Liberation Day III - and from today, dozens of countries will face painful Trump tariffs

It is "Liberation Day" III - the third tariff deadline set by Donald Trump. From today, countries without bilateral trade agreements face reciprocal tariffs - ranging from 25% to 50% - with a baseline of 15% to 20% for any not making a deal. He has delayed twice, from April to July and from July to August, but hammered this date home in his trademark caps-on style: "THE AUGUST FIRST DEADLINE STANDS STRONG, AND WILL NOT BE EXTENDED. A BIG DAY FOR AMERICA!!!" "Will not be extended" for anyone but Mexico, it seems. The country secured a 90-day extension at the last minute, with Mr Trump citing the "complexities" of the border. By close of business on the eve of deadline, he had a handful of framework deals - some significant - including the UK (10%), the EU, Japan and South Korea (15%), Indonesia and the Philippines (19%), Vietnam (20%). On the EU agreement, which he struck in Scotland, the president said: "It's a very powerful deal, it's a big deal, it's the biggest of all the deals." But what happened to the "90 deals in 90 days" touted by the White House earlier this year? The short answer is they were replaced by letters of instruction to pay a tariff set by the US. Amid of flurry of late activity, the US played hardball with major trading partners like Canada. "For the rest of the world, we're going to have things done by Friday," said US Commerce Secretary Howard Lutnick - the "rest of the world" meaning everyone but China. There is, apparently, the "framework of a deal" between the world's two largest economies, but talks between Washington and Beijing are continuing. Read more US news: In terms of wins, he can claim some significant deals and point to his tariffs having generated an impressive $27bn (£20.4bn) in June, not bad for a single month. But the legality of the approach is under siege - with the US Court of International Trade ruling that the "Liberation Day" tariffs exceeded the president's authority, with enforcement paused pending appeal. The deadline has stirred the pot, forcing a handful of deals onto the table. Whether they stick or survive legal scrutiny is far from settled. But the playbook remains the same - threaten the world with trade chaos, whittle it down, celebrate the wins, and pray no one checks what's legal.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store